---
schema_version: "secwatch.filing_event.v1"
accession: "0001520138-23-000444"
form_type: "8-K"
ticker: "AXIL"
cik: "0001718500"
company_name: "Axil Brands, Inc."
filed_at: "2023-10-13T23:59:59+00:00"
generated_at: "2026-06-10T00:05:04.869920+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Reviv3 Procare Q1 net sales up 44.1% to $6.1M, net income down 12%

## Summary
- Net sales for quarter ended Aug 31, 2023: $6.1M vs $4.2M prior year (+44.1%).
- Net income $154K vs $175.5K prior year; EPS $0.00 basic and diluted.
- Gross margin 76.1% vs 77.5%; operating expenses 73.3% of sales vs 72.8%.
- Cash balance $5.06M at quarter end, up from $4.83M; expanding global retail presence.

## SEC filing metadata
- accession: 0001520138-23-000444
- form_type: 8-K
- ticker: AXIL
- cik: 0001718500
- company_name: Axil Brands, Inc.
- filed_at: 2023-10-13T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1718500/000152013823000444/0001520138-23-000444-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1718500/000152013823000444/rviv-20231013_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001520138-23-000444
- JSON: https://secwatch.observer/filing/0001520138-23-000444.json
- Plain text: https://secwatch.observer/filing/0001520138-23-000444.txt

## Key facts
- Earnings Releases
  Axil Brands, Inc. reported financial results for the three months ended August 31, 2023.
  - Period: the three months ended August 31, 2023
  - Result: reported results
  source text: On October 13, 2023, Reviv3 Procare Company (the “Company”) issued a press release announcing its consolidated financial results for the three months ended August 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1718500/000152013823000444/0001520138-23-000444-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.